Impact of sports participation on components of metabolic syndrome in adolescents: ABCD growth study

2022 ◽  
Vol 0 (0) ◽  
Author(s):  
Veronica Alves de Menezes ◽  
Wesley Torres ◽  
Eduardo Duarte de Lima Mesquita ◽  
Lucas Gabriel de Moraes Chagas ◽  
Ana Elisa von Ah Morano ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Colorimetric Method ◽  
Sports Participation ◽  
Height Velocity ◽  
P Value ◽  
Growth Study ◽  
Small Magnitude ◽  
The Impact ◽  
Moderate Magnitude

Abstract Objectives This study aimed to analyze the impact of sports participation (12 months of practice) on the components of metabolic syndrome (MetS) in both sexes. Methods This is an observational longitudinal study, a part of which is entitled “Analysis of Behaviors of Children During Growth” (ABCD Growth Study), Presidente Prudente, São Paulo, Brazil. The sample was composed of 171 adolescents (112 boys and 59 girls), divided into non-sports and sports groups. High-density lipoprotein-cholesterol (HDL-c), triglycerides, and glucose were analyzed by the colorimetric method of dry chemistry and processed biochemically. Systolic blood pressure and diastolic blood pressure were measured using an automatic device. Body fat was estimated using a densitometry scanner. Results Adolescents who practiced sports were younger (p-value=0.001) and had a lower peak height velocity (p-value=0.001) than the non-sports group. The differences (Δ) after 12 months were of greater magnitude for the sports group when compared to the non-sports group (p-value=0.013), glucose (moderate magnitude in favor of the sports group; p-value=0.001), HDL-c (small magnitude in favor of the sports group; p-value=0.0015), and MetS (moderate magnitude in favor of the sports group; p-value=0.001). Conclusions The practice of sports in adolescents had a protective effect on the metabolic components of MetS.

scholarly journals Impact of sports participation on components of metabolic syndrome in adolescents: ABCD Growth Study 

2021 ◽  
Author(s):  
Verônica Alves Menezes ◽  
Wésley Torres ◽  
Eduardo Duarte de Lima Mesquita ◽  
Lucas Gabriel Moraes Chagas ◽  
Ana Elisa von Ah Morano ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Colorimetric Method ◽  
Sports Participation ◽  
P Value ◽  
Growth Study ◽  
Small Magnitude ◽  
The Metabolic Syndrome ◽  
The Impact ◽  
Moderate Magnitude

Abstract Objective The objective of this study was to analyze the impact of sports participation (12 months of practice) on components of the metabolic syndrome of both sexes.Methods Observational longitudinal study, party of the study entitled “Analysis of Behaviors of Children During Growth” (ABCD Growth Study), Presidente Prudente, SP. The sample consisted of 171 adolescents [112 boys and 59 girls], the groups were divided between non-sport and sport, according to the inclusion criteria: age 11 to 17 years; absence of known diseases previously diagnosed; no regular use of medications related to blood pressure or lipid metabolism; involvement in sports in the las 12 months (sports group) for at least one year without any regular involvement in sports training routines or physical exercises (non-sports group), signed written consent form parents and adolescents. The high-density cholesterol lipoproteins (HDL-c), triglycerides (TG), and glucose were analyzed by the dry chemical colorimetric method and processed biochemically. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were assessed using an automatic device. Body fat (BF) was estimated using a densitometry scanner. Ethnicity, sex, maturity, and body weight were treated as covariates.Results The adolescents involved in the sport were younger [p-value = 0.001] and with lower PVC [p-value = 0.001] than the non-sport group. The differences () after 12 months were of greater magnitude for the sports group when compared to non-sports group [p-value = 0.013], glucose (moderate magnitude in favor of the sports group; p-value = 0.001), HDL-c (small magnitude in favor of the sports group; p-value = 0.0015) and MetS (moderate magnitude in favor of the sports group; p-value = 0.001). Sport with high cardiorespiratory demand has more pronounced benefits than other groups. Sport seems to have a positive relationship in the variables sports participation, weekly volume, and load intensity. Conclusion Sports practice in adolescents had a protective effect on the metabolic components of the metabolic syndrome.

Abstract P298: The Impact of JNC VII Recommendations for Controlling Blood Pressure in a Heart Failure Disease Management Program

2011 ◽  
Vol 4 (suppl_1) ◽  
Author(s):  
George R Marzouka ◽  
Elyse Julian ◽  
Andre Dias ◽  
Leonardo Tamariz ◽  
Pat Trahan ◽  
...  
Keyword(s):  
Heart Failure ◽  
Blood Pressure ◽  
Disease Management ◽  
Pressure Control ◽  
Management Program ◽  
P Value ◽  
Baseline Visit ◽  
Heart Failure Disease Management ◽  
One Year ◽  
The Impact

Background: A significant correlation between hypertension (HTN) and long-term risk for heart failure (HF) exists. The aim of this study was (i) to assess what percent of patients enrolled in a heart failure disease management program (HFDMP) reach the JNC VII target goals for blood pressure control; (ii) to assess if there is a disparity in HTN control by race or ethnicity; (iii) and to assess the impact of reaching JNC VII targets for blood pressure control on survival. Methods: Patients with an ejection fraction ≤40% were enrolled into HFDMPs and screened for HTN, defined as blood pressure (BP) ≥ 130/80. Patients were titrated to beta blocker therapy and ace inhibitor therapy following the ACC/AHA HF guidelines. Final BP was measured after one year. Results: Mean baseline systolic BP (SBP) (N = 648) was 149.9 mmHg and mean baseline diastolic BP (DBP) was 90.5 mmHg. At one year, mean SBP decreased to 138.0 mmHg, DBP to 81.8 mmHg. There was no significant increase in survival for patients with BP ≤130 and ≤80 versus patients with HTN. There was a significant disparity in BP control in Blacks and Hispanics compared to whites (p<0.001) Conclusion: Disease management programs are an effective way to reduce BP in hypertensive patients, as well as keeping normotensive patients within JNC VII guidelines however health disparities persisted by race and ethnicity. Mean SBP and DBP of cohort at baseline Vs. 12 Month Follow up Blood pressure ≤ 130/80 mmHg Baseline Visit Last Visit P-Value SBP,m sd 110.9 (12.6%) 120.9 (22.2%) <0.001 DBP , m sd 67.1 (8.6%) 72.4 (13.7%) <0.001 Blood pressure > 130/80 mmHg Baseline Visit Last Visit P-Value SBP , m sd 149.9 (21.4%) 138.0 (24.6%) <0.001 DBP , m sd 90.5 (16.3%) 81.8 (16.8%) <0.001

scholarly journals Metabolic Syndrome—Role of Dietary Fat Type and Quantity

Nutrients ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 1438 ◽  
Author(s):  
Peter Clifton
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Dietary Fat ◽  
Saturated Fat ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
Fasting Insulin ◽  
Polyunsaturated Fat ◽  
Monounsaturated Fat ◽  
The Impact

Background: Metabolic syndrome increases the risk of cardiovascular disease (CVD) over and above that related to type 2 diabetes. The optimal diet for the treatment of metabolic syndrome is not clear. Materials and Methods: A review of dietary interventions in volunteers with metabolic syndrome as well as studies examining the impact of dietary fat on the separate components of metabolic syndrome was undertaken using only recent meta-analyses, if available. Results: Most of the data suggest that replacing carbohydrates with any fat, but particularly polyunsaturated fat, will lower triglyceride(TG), increase high density lipoprotein (HDL) cholesterol, and lower blood pressure, but have no effects on fasting glucose in normal volunteers or insulin sensitivity, as assessed by euglycemic hyperinsulinemic clamps. Fasting insulin may be lowered by fat. Monounsaturated fat (MUFA) is preferable to polyunsaturated fat (PUFA) for fasting insulin and glucose lowering. The addition of 3–4 g of N3 fats will lower TG and blood pressure (BP) and reduce the proportion of subjects with metabolic syndrome. Dairy fat (50% saturated fat) is also related to a lower incidence of metabolic syndrome in cohort studies.

scholarly journals Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review

Toxics ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 105
Author(s):  
Ilona Górna ◽  
Marta Napierala ◽  
Ewa Florek
Keyword(s):  
Insulin Resistance ◽  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Arterial Blood Pressure ◽  
Abdominal Obesity ◽  
Critical Review ◽  
Lifestyle Modifications ◽  
The Metabolic Syndrome ◽  
Arterial Blood ◽  
The Impact

The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much research has been conducted in the field of e-cigarettes and the risk of metabolic syndrome. Furthermore, taking into account the influence of e-cigarettes vaping on the individual components of metabolic syndrome, i.e, abdominal obesity, insulin resistance, dyslipidemia and elevated arterial blood pressure, the results are also ambiguous. This article is a review and summary of existing reports on the impact of e-cigarettes on the development of metabolic syndrome as well as its individual components. A critical review for English language articles published until 30 June 2020 was made, using a PubMed (including MEDLINE), Cochrane, CINAHL Plus, and Web of Science data. The current research indicated that e-cigarettes use does not affect the development of insulin resistance, but could influence the level of glucose and pre-diabetic state development. The lipid of profile an increase in the TG level was reported, while the influence on the level of concentration of total cholesterol, LDL fraction, and HDL fraction differed. In most cases, e-cigarettes use increased the risk of developing abdominal obesity or higher arterial blood pressure. Further research is required to provide more evidence on this topic.

scholarly journals Impaired Daytime Urinary Sodium Excretion Impacts Nighttime Blood Pressure and Nocturnal Dipping at Older Ages in the General Population

Nutrients ◽  
2020 ◽  
Vol 12 (7) ◽  
pp. 2013
Author(s):  
Rosaria Del Giorno ◽  
Chiara Troiani ◽  
Sofia Gabutti ◽  
Kevyn Stefanelli ◽  
Sandro Puggelli ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Sodium Excretion ◽  
Urinary Sodium Excretion ◽  
Urinary Sodium ◽  
P Value ◽  
Excretion Ratio ◽  
Cross Sectional ◽  
Nocturnal Dipping ◽  
Nighttime Blood Pressure ◽  
The Impact

The circadian rhythm of urinary sodium excretion is related to the diurnal blood pressure regulation (BP) and the nocturnal dipping pattern. The renal sodium excretion expressed as daytime/nighttime ratio impacts BP, but a limited number of studies have investigated this topic to date. In this cross-sectional study, we aimed to investigate the impact of different daily patterns of sodium excretion (comparing low with high ratios) on BP and nocturnal dipping and to explore the relationship with age. Twenty-four-hour ambulatory BP monitoring and daytime and nighttime urinary sodium collections were used to assess 1062 subjects in Switzerland. Analyses were performed according to the day/night urinary sodium excretion ratio quartiles (Q1–Q4) and by age group (≤50 and ≥50 years). Subjects in Q1 can be considered low excretors of sodium during the daytime since the rate of sodium excretion during the daytime was 40% lower than that of subjects in Q4. Quartiles of the day/night urinary sodium excretion ratio showed that subjects in Q1 were 7 years older and had respectively 6 and 5 mmHg higher nighttime systolic and diastolic BP and a higher nocturnal dipping compared with subjects in Q4 (p-value ≤0.001). Associations found were significant only for subjects older than 50 years (all p < 0.05). The present results suggest that a decreased capacity to excrete sodium during daytime is more prevalent as age increases and that it impacts nighttime blood pressure and nocturnal dipping in older subjects.

scholarly journals The impact of lemon aromateraphy and breath relaxation in blood pressure on hypertensive elderly at Patukan Gamping Sleman Yogyakarta

2019 ◽  
Vol 1 (1) ◽  
pp. 9-15
Author(s):  
Ana Apriana Murtianingsih ◽  
Edy Suprayitno
Keyword(s):  
Blood Pressure ◽  
Cardiovascular Disease ◽  
Treatment Group ◽  
Medical Treatment ◽  
Sampling Technique ◽  
P Value ◽  
Experiment Research ◽  
Heart Performance ◽  
Equivalent Control ◽  
The Impact

Hypertension is defined as the increase of chronicle blood pressure that is usually happened on elderly people. Hypertension belongs to one of Cardiovascular Disease (CVD) that becomes the cause of 80% mortality in Indonesia. One of non-pharmacological medical treatment for hypertension was by using the lemon aromatic therapy and inner relaxation breath. This therapy aims to give calming and comforting effect that leads to the decrease of heart performance and blood pressure.To find out the impact of lemon aromatic therapy and inner breath relaxation toward blood pressure on elderly people’s hypertension. This research belongs to Quasy Experiment Research Design by implementing Non Equivalent Control Groupwith one treatment group and one controlled group. This research implemented total sampling technique with 22 respondents in total. The mann-whitneystatistical analysis showed that p value 0,000 of the diastole blood pressure was at 0,016 with trustworthiness at α 0,05. There is impact of lemon aromatic therapy and inner relaxation breath toward the decrease of blood pressure on the hypertension patient. The patient of hypertension is suggested to use lemon aromatic therapy and inner relaxation breath as one of non-pharmacological medical treatment that can reduce the high blood pressure.

scholarly journals Prevalence of cardiac autonomic dysfunction in patients with metabolic syndrome: a cross-sectional, observational study

2019 ◽  
Vol 7 (4) ◽  
pp. 987
Author(s):  
Akash C. Lohakare ◽  
Pawan Mehta ◽  
Shuchi Singh
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Observational Study ◽  
Autonomic Dysfunction ◽  
Strong Association ◽  
Fasting Blood Glucose ◽  
Categorical Variables ◽  
P Value ◽  
Cross Sectional ◽  
Cardiac Autonomic Dysfunction

Background: Cardiovascular autonomic neuropathy (CAN) is a distinguished disorder associated with diabetes mellitus and metabolic syndrome. The pathogenesis of CAN in patients with metabolic syndrome still remains unclear. This study was undertaken to assess the prevalence of cardiac autonomic dysfunction in patients with metabolic syndrome and to correlate different parameters of metabolic syndrome with cardiac autonomic dysfunction.Methods: In this cross-sectional observational study, total 100 consecutive cases meeting the inclusion criteria and attending the Department of Medicine in Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi were enrolled. 50 subjects who satisfied the IDF criteria of metabolic syndrome were taken as cases and remaining 50 subjects (age and gender matched) who did not satisfy the IDF criteria were taken as controls. Comparison of categorical variables was made using chi-square or Fisher’s exact test. P-value <0.05 was considered as statistically significant.Results: Majority of study population (i.e., 42%) belonged to the age group of 41-50 years. Overall prevalence of cardiac autonomic dysfunction (CAD) was 25%. Prevalence of CAD among cases and controls was 38% and 12%, respectively. Overall distribution of various parameters like waist circumference, fasting blood glucose, blood pressure, HDL-C and serum triglycerides was assessed in all subjects with respect to CAD. Statistically significant association of these parameters was seen with CAD (p-value ≤0.01).Conclusions: In this study, strong association was found between CAD and central obesity, impaired fasting glucose, high blood pressure and dyslipidemia. Thus, the metabolic disorders are good predictors of CAD.

Sports participation and adiposity do not mediate the relationship between birth weight and arterial thickness in adolescents: ABCD Growth Study

2019 ◽  
Vol 29 (5) ◽  
pp. 620-625
Author(s):  
Jacqueline Urban ◽  
Suziane Cayres ◽  
Jamile Codogno ◽  
Bruna Turi-Lynch ◽  
Alessandra Mantovani ◽  
...  
Keyword(s):  
Birth Weight ◽  
Effect Size ◽  
Sports Participation ◽  
Intima Media Thickness ◽  
P Value ◽  
C Reactive Protein ◽  
Growth Study ◽  
Reactive Protein ◽  
Small Effect Size ◽  
The Relationship

AbstractObjective:To analyse the relationship of altered birth weight with metabolic and cardiovascular outcomes among adolescents, as well as to identify if sports participation is able to attenuate or even eliminate the impact of birth weight on health outcomes.Methods:Cross-sectional study (Analysis of Behaviours of Children During Growth [ABCD Growth Study]). Adolescents with age ranging from 11 to 18 years old (14.7±2.1) stratified according to normal (n = 230) and altered (n = 35) birth weight composed the sample. Birth weight was self-reported by adolescent’s parents. Sports participation was assessed by face-to-face interview. Carotid intima–media thickness (CIMT) and femoral intima–media thickness (FIMT) were measured using an ultrasound device. C-reactive protein levels were used to assess the inflammatory status. Blood pressure, Z score of metabolic risk (dyslipidemia and glucose), adiposity, and insulin resistance were covariates.Results:In the crude model, FIMT (p value = 0.037) and C-reactive protein (p value = 0.029) were affected by altered birth weight. In the adjusted models, altered birth weight affected FIMT (p value = 0.048; small effect size of 1.7%), independently of sports participation. For C-reactive protein, previous time of engagement in sports (p value = 0.001; small effect size of 4.8%) affected C-reactive protein, independently of birth weight.Conclusion:Vascular structure seems to be affected by birth weight in adolescents, while its impact on inflammation seems to be attenuated by the regular engagement in sports.

Impact of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a randomized clinical trial

2020 ◽  
Author(s):  
Eduardo Montero ◽  
Mercedes López ◽  
Honorato Vidal ◽  
María Martínez ◽  
Jorge Marrero ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Clinical Trial ◽  
Periodontal Therapy ◽  
Periodontal Treatment ◽  
Markers Of Inflammation ◽  
Severe Periodontitis ◽  
Secondary Outcomes ◽  
Hs Crp ◽  
The Impact

Abstract Background Although there is evidence of positive effect of periodontal therapy on systemic inflammation, this response is highly variable among subjects. It was the aim of this clinical investigation to determine the impact of periodontal treatment on systemic markers of inflammation in patients with metabolic syndrome (MetS) and periodontitis. Methods In this parallel-arm, double blind, randomized controlled clinical trial, 63 patients with MetS and severe periodontitis were randomly assigned to receive intensive periodontal treatment (IPT; scaling and root planing plus azithromycin 500 mg, q.d., for three days) or minimal periodontal treatment (MPT; supragingival professional mechanical plaque removal plus a placebo). The primary outcome was the impact of the tested interventions on hs-CRP serum levels at 6 months. As secondary outcomes, differences in the levels of cytokines, markers of prothrombotic states, carbohydrate and lipids metabolism, as well as blood pressure, were measured at 3 and 6 months after therapy. Results The ITT population consisted on 63 subjects randomly assigned to either MPT (n = 31) or IPT (n = 32) groups. At baseline, mean hs-CRP was 3.9 mg/L (standard deviation, SD = 2.9) and 3.9 mg/L (SD = 3.4), respectively, and no significant differences in their cardiometabolic risk profiles were detected between groups. After 6 months, unadjusted mean hs-CRP were 2.9 mg/L (standard error, SE = 0.4) and 4.0 (SE = 0.8), respectively. Adjusting for baseline hs-CRP, sex, age, smoking status and body mass index, hs-CRP was 1.2 mg/L (95% confidence interval, [CI 0.4; 2.0]; p = 0.004) lower in the IPT group than in the MPT group. In the secondary outcomes, significant reductions in IL-1β, TNF-α, HbA1c and blood pressure were observed in the IPT group at 3 months, when compared to the MPT group. Conclusion Effective periodontal treatment significantly reduced hs-CRP after 6 months in patients with MetS and severe periodontitis. Periodontal therapy might be useful to reduce cardiovascular risk in these patients. Trial registration: ClinicalTrials.gov Registration Number: NCT03960216.

Sign in / Sign up

Export Citation Format

Share Document